Contribution of an adenine to guanine single nucleotide polymorphism of the matrix metalloproteinase-13 (MMP-13) -77 promoter region to the production of anticyclic citrullinated peptide antibodies in patients with HLA-DRB1*shared epitope-negative rheumatoid arthritis

Modern Rheumatology

Volumn 21, Issue 3, 2011, Pages 240-243

  Iwamoto, Naoki ^a   Kawakami, Atsushi ^a   Arima, Kazuhiko ^a   Tamai, Mami ^a   Nakamura, Hideki ^a   Kawashiri, Shin Ya ^a   Kita, Junko ^a   Okada, Akitomo ^a   Koga, Tomohiro ^a   Kamachi, Makoto ^a   Yamasaki, Satoshi ^a   Ichinose, Kunihiro ^a   Ida, Hiroaki ^a   Origuchi, Tomoki ^a   Eguchi, Katsumi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Anti CCP antibodies; MMP 13; Polymorphism; Rheumatoid arthritis

Indexed keywords

ADENINE; COLLAGENASE 3; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; EPITOPE; GUANINE; HLA DR ANTIGEN;

ADULT; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ARTHRITIS, RHEUMATOID; ASIAN CONTINENTAL ANCESTRY GROUP; AUTOANTIBODIES; EPITOPES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-DR ANTIGENS; HUMANS; JAPAN; MALE; MATRIX METALLOPROTEINASE 13; MIDDLE AGED; PEPTIDES, CYCLIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 79960141445     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-010-0375-6     Document Type: Article

References (17)

1. Cm Deighton DJ Walker 1991 The familial nature of rheumatoid arthritis Ann Rheum Dis 50 62 65 1994873 10.1136/ard.50.1.62 1:STN:280: DyaK3M7js1ehuw%3D%3D
2. Cm Deighton DJ Walker ID Griffiths DF Roberts 1989 The contribution of HLA to rheumatoid arthritis Clin Genet 36 178 182 2676268 10.1111/j.1399-0004. 1989.tb03185.x 1:STN:280:DyaK3c%2Fgtlymtg%3D%3D (Pubitemid 19218460)
3. K Yamamoto R Yamada 2007 Lessons from a genomewide association study of rheumatoid arthritis N Engl J Med 357 1199 1209 10.1056/NEJMe078174 (Pubitemid 47443187)
4. D Wernicke C Seyfert E Gromnica-Ihle, et al. 2006 The expression of collagenase 3(MMP-13) mRNA in the synovial tissue is associated with histopathologic type II synovitis in rheumatoid arthritis Autoimmunity 39 307 313 16891219 10.1080/08916930600807709 1:CAS:528:DC%2BD28Xptlalu7s%3D (Pubitemid 44203506)
5. M Fiedorczyk PA Kilimiuk S Sierakowski, et al. 2006 Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with early rheumatoid arthritis J Rheumatol 33 1523 1529 16881109 1:CAS:528:DC%2BD28Xpt1Oksbo%3D (Pubitemid 44168822)
6. S Yoon H Kuivaniemi Z Gatalica, et al. 2002 MMP13 promoter polymorphism is associated with atherosclerosis in the abdominal aorta of young black males Matrix Biol 21 487 498 12392760 10.1016/S0945-053X(02)00053-7 1:CAS:528:DC%2BD38XotVCnurs%3D (Pubitemid 35248274)
7. S Ye N Patodi K Wallker-Bonet, et al. 2007 Variation in the matrix metalloproteinase-3, -7, -12 and -13 gene is associated with functional status in rheumatoid arthritis Int J Immunogenet 34 81 85 17373931 10.1111/j.1744-313X. 2007.00664.x 1:CAS:528:DC%2BD2sXktVOjsbo%3D (Pubitemid 46435094)
8. FC Arnett SM Edworthy DA Bloch, et al. 1988 The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 315 324 3358796 10.1002/art.1780310302 1:STN:280: DyaL1c7pt1Ohsg%3D%3D (Pubitemid 18091653)
9. N Iwamoto A Kawakami M Tamai, et al. 2009 Determination of the subset of Sjögren's syndrome with articular manifestations by anticyclic citrullinated peptide antibodies J Rheumatol 36 113 115 19132785 1:CAS:528:DC%2BD1MXit1Cmtr4%3D
10. M Tamai A Kawakami M Uetani, et al. 2009 A prediction rule for disease outcome in patients with undifferentiated arthritis using magnetic resonance imaging of the wrists and finger joints and serologic autoantibodies Arthritis Rheum 61 772 778 19479686 10.1002/art.24711 1:CAS:528:DC%2BD1MXot12rs7Y%3D
11. M Tamai A Kawakami, et al. 2007 Bone edema determined by magnetic resonance imaging reflects severe disease status in patients with early-stage rheumatoid arthritis J Rheumatol 34 2154 2157 17918786 1:CAS:528: DC%2BD2sXhsVeksLzL (Pubitemid 350076872)
12. T Shibue N Tsuchiya T Komata, et al. 2000 Tumor necrosis factor alpha 5′-flanking region, tumor necrosis factor receptor II, and HLA-DRB1 polymorphisms in Japanese patients with rheumatoid arthritis Arthritis Rheum 43 753 757 10765919 10.1002/1529-0131(200004)43:4<753::AID-ANR5>3.0.CO;2-O 1:CAS:528:DC%2BD3cXivFOisbY%3D
13. SW Syversen PI Gaarder, et al. 2008 High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study Ann Rheum Dis 67 212 217 17526555 10.1136/ard.2006.068247 1:STN:280:DC%2BD1c%2FisVygug%3D%3D (Pubitemid 351183310)
14. AJ Svendsen NV Holm, et al. 2002 Relative importance of genetic effects in rheumatoid arthritis: historical cohort study of Danish nationwide twin population BMJ 324 264 266 11823356 10.1136/bmj.324.7332.264 (Pubitemid 34121835)
15. K Lundberg S Nijenhuis ER Vossenaar, et al. 2005 Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity Arthritis Res Ther 7 458 467 10.1186/ar1697
16. KA Kuhn L Kulik B Tomooka, et al. 2006 Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis J Clin Invest 116 961 973 16585962 10.1172/JCI25422 1:CAS:528:DC%2BD28XjsVWntb0%3D
17. M Pedersen S Jacobsen P Garred, et al. 2007 Strong combined gene-environment effects in anti-cyclic citrullinated peptide-positive rheumatoid arthritis: a nationwide case-control study in Denmark Arthritis Rheum 56 1446 1453 17469102 10.1002/art.22597 (Pubitemid 46764072)